Evidence map›Paper›PMID 42668088›Full record

ArticleCellular and molecular gastroenterology and hepatology2026

Hepatitis B Surface Antigen Directly Alters Dendritic Cell-Mediated Natural Killer Cell Responses.

Lucile Dumolard, Marie-Noelle Hilleret, Mylene Pezet, Thomas Decaens, Philippe Saas, Evelyne Jouvin-Marche, Patrice N Marche, Caroline Aspord, Zuzana Macek Jilkova

Abstract read
In one paragraph

Article in Cellular and molecular gastroenterology and hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lucile DumolardInstitute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, University Grenoble Alpes, Grenoble, France.
Marie-Noelle HilleretInstitute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, University Grenoble Alpes, Grenoble, France; Hepato-Gastroenterology and Digestive Oncology Department, CHU Grenoble Alpes, Grenoble, France.
Mylene PezetInstitute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, University Grenoble Alpes, Grenoble, France.
Thomas DecaensInstitute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, University Grenoble Alpes, Grenoble, France; Hepato-Gastroenterology and Digestive Oncology Department, CHU Grenoble Alpes, Grenoble, France.
Philippe SaasInstitute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, University Grenoble Alpes, Grenoble, France; Etablissement Français du Sang Auvergne-Rhone-Alpes, R&D Laboratory, Grenoble, France.
Evelyne Jouvin-MarcheInstitute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, University Grenoble Alpes, Grenoble, France.
Patrice N MarcheInstitute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, University Grenoble Alpes, Grenoble, France.
Caroline AspordInstitute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, University Grenoble Alpes, Grenoble, France; Etablissement Français du Sang Auvergne-Rhone-Alpes, R&D Laboratory, Grenoble, France. Electronic address: caroline.aspord@efs.sante.fr.
Zuzana Macek JilkovaInstitute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, University Grenoble Alpes, Grenoble, France; Hepato-Gastroenterology and Digestive Oncology Department, CHU Grenoble Alpes, Grenoble, France. Electronic address: zmacekjilkova@chu-grenoble.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND &

aimsHepatitis B, caused by the hepatitis B virus, is a significant global health concern, often leading to chronic hepatitis B in individuals unable to mount an effective immune response. Chronic hepatitis B virus substantially increases the risk of severe liver diseases, including cirrhosis and hepatocellular carcinoma. Dendritic cells and natural killer cells play crucial roles in the early immune response to hepatitis B virus, but their function is compromised in patients with chronic hepatitis B. We investigated how hepatitis B surface antigen influences the interplay between dendritic cell subpopulations and natural killer cells.

methodsBlood-derived dendritic cell subsets were pre-exposed to hepatitis B surface antigen and then cocultured with natural killer cells under various stimulation conditions. We subsequently evaluated the modulations of dendritic cells and the phenotypic and functional responses of natural killer cells. Similarly, dendritic cell subsets were exposed to serum from hepatitis B virus-infected individuals with varying levels of hepatitis B surface antigen or directly purified from patients with hepatitis B virus to assess their ability to stimulate natural killer cell responses.

resultsOur findings show that hepatitis B surface antigen disrupts type 2 conventional dendritic cell-mediated natural killer cell activation through Toll-like receptor 7 and 8-dependent pathways and type 1 dendritic cell-mediated natural killer cell degranulation via Toll-like receptor 3-dependent mechanisms. Exposure of plasmacytoid dendritic cells to hepatitis B surface antigen alters natural killer cell activation, phenotype, and degranulation through Toll-like receptor 9-dependent pathways. This impairment was recapitulated following exposure to serum from hepatitis B virus-infected patients in a hepatitis B surface antigen-dependent manner. Consistently, circulating hepatitis B surface antigen in patients with chronic hepatitis B virus infection was associated with impaired plasmacytoid dendritic cell-mediated natural killer cell cytotoxicity.

conclusionsThese results uncover key mechanisms by which hepatitis B surface antigen modulates plasmacytoid dendritic cell-natural killer cell interactions, shedding light on how hepatitis B virus evades innate immune responses and contributes to immune dysfunction.

Indexed as

Dendritic CellsHBsAgHepatitis BNK Cells

Identifiers

PMID42668088
PMCPMC13675923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.